<DOC>
	<DOCNO>NCT01681745</DOCNO>
	<brief_summary>This study design characterize biological response epidermis , dermis subcutaneous tissue treatment myoscience Cryo-Touch III system .</brief_summary>
	<brief_title>Probe Configuration Time-Temperature Dose Ranging Understanding Skin Lesion Effects</brief_title>
	<detailed_description />
	<criteria>Male female , 18 70 year old Subject willing able give write informed consent . Subject commit undergo abdominoplasty procedure independent study . Subject willing able comply study instruction commit visit duration study . Subject good general health free disease state physical condition might impair evaluation investigator 's opinion , expose subject unacceptable risk study participation . Subject currently enrol investigational drug device study specifically target abdominal area . Subject currently smoke . Subject clot disorder and/or use anticoagulant ( e.g. , warfarin , clopidogrel , etc . ) within seven ( 7 ) day prior administration device . Subject use oral inhaled steroid last 14 day and/or chronic user inhale oral steroid past investigator feel subject may compromise wind heal . Subject use topical steroid abdominal area within last 30 day . Subject systemic immunosuppressive therapy . Subject prior surgery and/or treatment alters subcutaneous anatomy target treatment site : liposuction , cryolipolysis , highintensity focus ultrasound . History abdominal hernia . Subject follow condition : Allergy intolerance lidocaine , Other local skin condition ( e.g. , skin infection ) target treatment site , Any physical psychiatric condition investigator 's opinion would prevent adequate study participation . Chronic medical condition use medication investigator 's opinion would affect study participation wound heal ( diabetes , hepatitis , HIV , etc. ) . Subject know noncompliant unlikely comply requirement study protocol ( e.g. , due alcoholism , drug dependency , mental incapacity ) opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>